Bone-seeking TRAP conjugates: Surprising observations and their implications on the development of gallium-68-labeled bisphosphonates

EJNMMI Research

Volumn 2, Issue 1, 2012, Pages 1-4

  Notni, Johannes ^a   Plutnar, Jan ^b   Wester, Hans Jürgen ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Bisphosphonates; Bone seekers; Gallium 68; MicroPET Bone imaging; Positron emission tomography

Indexed keywords

CHELATING AGENT; GALLIUM TETRAETHYL (1 AMINOPROPYLENE)BIPHOSPHONATE GA 68; GALLIUM TETRAETHYL(AMINOMETHYLENE)BIPHOSPHONATE GA 68; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BONE SCINTISCANNING; CONJUGATE; DRUG BLOOD LEVEL; DRUG BONE LEVEL; DRUG STRUCTURE; ISOTOPE LABELING; KIDNEY CLEARANCE; MALE; MICRORADIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RAT;

EID: 84875912398     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-2-13     Document Type: Article

References (18)

1. Mukherjee S, Huang C, Guerra F, Wang K, Oldfield E: Thermodynamics of bisphosphonates binding to human bone: a two-site model. J Am Chem Soc 2009, 131:8375-8376.
2. Mukherjee S, Song Y, Oldfield E: NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model. J Am Chem Soc 2008, 130:1264-1273.
3. Ebetino FH, Hogan AML, Sun ST, Tsoumpra MK, Duan XC, Triffitt JT, Kwaasi AA, Dunford JE, Barnett BL, Oppermann U, Lundy MW, Boyde A, Kashemirov BA, McKenna CE, Russell RGG: The relationship between the chemistry and biological activity of the bisphosphonates. Bone 2011, 49:20-33.
4. Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP: Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Design 2010, 16:2950-2960.
5. Shapiro JR, Sponsellor PD: Osteogenesis imperfecta: questions and answers. Curr Opin Pediatr 2010, 21:709-716.
6. Le Goff B, Guillot P, Glemarec J, Berthelot JM, Maugars Y: A comparison between bisphosphonates and other treatments for osteoporosis. Curr Pharm Design 2010, 16:3037-3044.
7. Kubíček V, Rudovský J, Kotek J, Hermann P: Vander Elst L, Muller RN, Kolar ZI, Wolterbeek HT, Peters JA, Lukeš I: A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting. J Am Chem Soc 2005, 127:16477-16485.
8. Vitha T, Kubíček V, Hermann P: Vander Elst L, Muller RN, Kolar ZI, Wolterbeek HT, Breeman WAP, Lukeš I, Peters JA: Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: boneseeking agents for imaging and therapy. J Med Chem 2008, 51:677-683.
9. Fellner M, Baum RP, Kubíček V, Hermann P, Lukeš I, Prasad V, Rösch F: PET/CT imaging of osteoblastic bone metastases with 68 Gabisphosphonates: first human study. Eur J Nucl Med Mol Imaging 2010, 37:834.
10. Suzuki K, Satake M, Suwada J, Oshikiri S, Ashino H, Dozono H, Hino A, Kasahara H, Minamizawa T: Synthesis and evaluation of a novel 68 Gachelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging. Nucl Med Biol 2011, 38:1011-1018.
11. Notni J, Hermann P, Havlíčková J, Kotek J, Kubíček V, Plutnar J, Loktionova N, Riss PJ, Rösch F, Lukeš I: A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68 Ga tracers for positron emission tomography. Chem Eur J 2010, 16:7174-7185.
12. Šimeček J, Schulz M, Notni J, Plutnar J, Kubíček V, Havlíčková J, Hermann P: Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and NOTA: phosphinate-containing ligands as unique chelators for trivalent gallium. Inorg Chem 2012, 51:577-590.
13. Notni J, Šimeček J, Hermann P, Wester HJ: TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals. Chem Eur J 2011, 17:14718-14722.
14. Clausen J, Edeling CJ, Fogh J: 67 Ga binding to human serum proteins and tumor components. Cancer Res 1974, 34:1931-1937.
15. Chikh Z, Ha-Duong NT, Miquel G: El Hage Chahine JM: Gallium uptake by transferrin and interaction with receptor 1. J Biol Inorg Chem 2007, 12:90-100.
16. Otsuki H, Brunetti A, Owens ES, Finn RD, Blasberg RG: Comparison of iron-59, indium-111, and gallium-69 transferrin as a macromolecular tracer of vascular permeability and the transferrin receptor. J Nucl Med 1989, 10:1676-1685.
17. Bernstein LR: Mechanisms of therapeutic activity for gallium. Pharmacol Rev 1998, 50:665-682.
18. Sánchez-Crespo A, Andreo P, Larsson SA: Positron flight in human tissues and its influence on PET image spatial resolution. Eur J Nucl Med Mol Imaging 2004, 31:44-51.